Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Technical Guidance for CDK9 Inhibitor (A3294) in Transcripti
2026-06-18
CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for precise inhibition of cyclin dependent kinase 9, supporting studies of transcription elongation and HIV-1 propagation with minimal cytotoxicity. It should not be employed in experiments requiring broad-spectrum CDK inhibition or long-term storage of working solutions.
-
Gentamycin Sulfate: Applied Workflows in Resistance Research
2026-06-18
Gentamycin Sulfate from APExBIO delivers precision and reliability for dissecting bacterial protein synthesis and resistance mechanisms, especially in Gram-negative models. This guide translates cutting-edge resistance epidemiology into actionable protocols, troubleshooting solutions, and comparative insights that optimize your experimental outcomes.
-
CD36-Mediated Lipid Sensing Drives Immune Escape in AML Cell
2026-06-17
Guo et al. reveal that CD36 enables acute myeloid leukemia (AML) cells to suppress T cell activity by sensing oxidized lipids and palmitate, activating an immunosuppressive signaling axis. These findings highlight a non-canonical lipid metabolism pathway underlying immune escape and resistance to hypomethylating therapy in AML, offering new angles for therapeutic intervention.
-
GSK621 (SKU B6020): Optimizing AMPK Agonist Assays in Metabo
2026-06-17
This article provides a scenario-driven, evidence-based guide for biomedical researchers leveraging GSK621 (SKU B6020) as a potent AMPK agonist. It addresses key workflow challenges in acute myeloid leukemia and immunometabolic research, offering practical insights on protocol optimization, data interpretation, and product selection. By integrating recent literature and real-world lab scenarios, the discussion highlights how GSK621 from APExBIO delivers reproducibility and robust assay performance.
-
Evaluating Fumagillin’s Efficacy Against Azumiobodo hoyamush
2026-06-16
This article examines a pivotal study investigating the in vitro and in vivo effectiveness of various antiprotozoal agents, including Fumagillin, against Azumiobodo hoyamushi, the causative parasite of soft tunic syndrome in Halocynthia roretzi. The research clarifies Fumagillin’s moderate antiparasitic potential and discusses its implications for aquaculture disease management and antiparasitic research.
-
Viral vIRD-Mediated RIPK3 Degradation Regulates Inflammation
2026-06-16
Liu et al. identify a class of viral proteins (vIRD) in orthopoxviruses that induce proteasome-dependent degradation of the necroptosis adaptor RIPK3, thereby controlling virus-induced inflammation and replication. This work uncovers a novel viral immune evasion mechanism with implications for studying host-pathogen interactions and regulated cell death pathways.
-
Indomethacin: A Precision Tool for Adipocyte and Membrane Re
2026-06-15
Explore how Indomethacin, a nonsteroidal anti-inflammatory drug, enables advanced inflammation research and lipid metabolism studies through its unique Cox-1 selectivity and PPARγ agonism. This article reveals new mechanistic insights and practical assay guidance for researchers.
-
C-Terminal Mutations in VZV gE Enhance mRNA Vaccine Efficacy
2026-06-15
This study evaluates how carboxyl-terminal mutations in varicella-zoster virus glycoprotein E (gE) affect mRNA vaccine performance. Findings indicate that specific C-terminal modifications improve both humoral and cellular immune responses, suggesting enhanced vaccine candidates for varicella and zoster.
-
LGK-974 (PORCN Inhibitor): Unraveling Wnt Pathway Dynamics i
2026-06-14
Explore how LGK-974, a potent PORCN inhibitor, enables precise dissection of Wnt signaling in both developmental biology and Wnt-driven cancer research. This in-depth analysis uniquely bridges evolutionary insights with advanced laboratory applications.
-
DFCP1 Modulates Starvation-Induced ATGL Activity in Lipid Dr
2026-06-13
A recent study reveals that DFCP1 acts as a nutrient-sensitive regulator of lipid droplet lipolysis by controlling ATGL localization and activity during starvation. This mechanistic insight advances our understanding of lipid storage and mobilization, with implications for research into metabolic stress and protein stability assays.
-
PKH26 Red Fluorescent Cell Linker Kit: Technical Use and QC
2026-06-12
The PKH26 Red Fluorescent Cell Linker Kit provides stable, minimally toxic fluorescent labeling of cell membrane lipid regions for cell tracing and proliferation detection in both in vitro and in vivo research. It is not suitable for intracellular or non-membrane applications and requires strict adherence to protocol parameters for reproducible, reliable results.
-
Phosbind Acrylamide: Precision Phosphate-Binding for SDS-PAG
2026-06-12
Phosbind Acrylamide empowers researchers to dissect phosphorylation states rapidly and antibody-free, streamlining SDS-PAGE–based phosphorylation analysis. Its robust phosphate-binding chemistry enables direct, quantitative visualization of phospho-isoforms, driving advances in circadian signaling and kinase pathway research.
-
Optimizing Cancer Assays with BV6: From IAP Antagonism to Ra
2026-06-11
BV6, a potent IAP antagonist, empowers researchers to reliably induce apoptosis and sensitize cancer cells to chemoradiotherapy. This article dives into advanced workflows, actionable troubleshooting, and protocol optimization, bridging foundational mechanism with practical assay outcomes.
-
EPI-001: Unraveling AR N-Terminal Domain Inhibition in Cance
2026-06-11
Explore the advanced applications of EPI-001, a potent androgen receptor N-terminal domain inhibitor, in prostate and triple-negative breast cancer research. This article provides a deep dive into its molecular mechanism, protocol optimization, and translational impact, offering uniquely actionable insights for AR-driven disease models.
-
Applied Workflows for Resiniferatoxin (RTX) in TRPV1 Researc
2026-06-10
Resiniferatoxin (RTX) enables ultra-selective, long-lasting TRPV1 desensitization, offering unmatched control in pain and neurogenic inflammation models. This guide translates recent mechanistic insights and reference-backed troubleshooting into actionable protocols for reproducible, high-impact research.